Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RTA 402 Phase 2 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients With Chronic Kidney Disease and Type 2 Diabetes).

Trial Profile

RTA 402 Phase 2 Clinical Trial (A Randomized, Double-blind, Placebo-controlled Clinical Trial in Patients With Chronic Kidney Disease and Type 2 Diabetes).

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 11 Oct 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bardoxolone methyl (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms TSUBAKI study
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 11 Oct 2019 According to a Reata Pharmaceuticals media release, safety data from four studies ( NCT03019185, NCT03366337, NCT02316821 and NCT02036970 will be presented at at the American Society of Nephrology Kidney Week 2019 Annual Meeting. Abstract are available on the conference website at https://www.asn-online.org/education/kidneyweek/archives/.
    • 31 Aug 2018 Biomarkers information updated
    • 04 Jun 2018 According to a Reata Pharmaceuticals media release, based on the data of this study and other data, Kyowa Hakko Kirin received SAKIGAKE Designation for bardoxolone for the treatment of diabetic kidney disease by the Japanese Ministry of Health, Labour and Welfare in March 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top